RadNet navigates effects of pandemic in Q1
Acquisitions and price increases helped imaging services provider RadNet to...Read more on AuntMinnie.comRelated Reading: RadNet to acquire AI software firm DeepHealth RadNet forms partnership with AI developer RadNet inks Del. contract RadNet launches AI division with Nulogix acquisition RadNet inks deal to acquire Calif. radiology group (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 13, 2020 Category: Radiology Source Type: news

A formative figure in the company's history: Roche Honorary Chairman Fritz Gerber dies at the age of 91
Basel, 11 Mai 2020- On May 10th 2020 Dr. h.c. Fritz Gerber died in his 92nd year. For more than two decades, he had shaped Roche's development into a leading global healthcare company in an exceptionally successful dual role as Group CEO (1978-1998) and Chairman of the Board (1978-2001). He remained closely associated with Roche throughout his life as Honorary Chairman. Starting at the end of the 1970s, Fritz Gerber led the company from a difficult situation to new success. Under his leadership, Roche's Group structures were fundamentally renewed and decentralized – ranging from focusing on the core businesses to mod...
Source: Roche Investor Update - May 11, 2020 Category: Pharmaceuticals Source Type: news

A formative figure in the company's history: Roche Honorary Chairman Fritz Gerber dies at the age of 91
Basel, 11 Mai 2020 - On May 10th 2020 Dr. h.c. Fritz Gerber died in his 92nd year. For more than two decades, he had shaped Roche's development into a leading global healthcare company in an exceptionally successful dual role as Group CEO (1978-1998) and Chairman of the Board (1978-2001). He remained closely associated with Roche throughout his life as Honorary Chairman. Starting at the end of the 1970s, Fritz Gerber led the company from a difficult situation to new success. Under his leadership, Roche's Group structures were fundamentally renewed and decentralized – ranging from focusing on the core businesses to mo...
Source: Roche Media News - May 11, 2020 Category: Pharmaceuticals Source Type: news

BioPharmX Corporation Urges Stockholders to Vote Now on Proposed Merger with Timber Pharmaceuticals
CAMPBELL, Calif., May 8, 2020 -- (Healthcare Sales & Marketing Network) -- BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX") is urging its stockholders to vote now on the proposed merger of BioPharmX with Timber Pharmaceuticals LLC (&quo... Biopharmaceuticals, Drug Delivery, Mergers & Acquisitions BioPharmX, Timber Pharmaceuticals, HyantX, Topical Delivery, ichthyosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 8, 2020 Category: Pharmaceuticals Source Type: news

The Dedalus Group, Participated by Ardian, Acquires Part of the Agfa-Gevaert Group's Healthcare IT Business
The Dedalus Group, a leading European company, and one of the worldwide main ones, active in clinical healthcare information systems to support clinical professionals and organizations in order to improve their care quality level according to an economic and financial sustainability approach, announces that it has completed the acquisition of part of Agfa HealthCare (Agfa-Gevaert Group) IT business for the healthcare sector. (Source: eHealth News EU)
Source: eHealth News EU - May 7, 2020 Category: Information Technology Tags: Featured Industry Business and Industry Source Type: news

Centene signs lease to expand in Florida
The new lease follows Centene's acquisition of WellCare Health Plans earlier this year. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 6, 2020 Category: Pharmaceuticals Authors: Ashley Gurbal Kritzer Source Type: news

Temple, Jefferson call off Fox Chase Cancer Center deal
Jefferson University and Temple University have called off the planned acquisition of Fox Chase Cancer Center by Jefferson because of the "devastating economic impact" of Covid-19. The organizations announced the termination of the transaction late Tuesday, saying the decision was amicable. “This transaction is the latest casualty of Covid-19,” said Dr. Stephen K. Klasko, president of Thomas Jefferson University and CEO of Jefferson Health. “Because of the tremendous impact that the virus… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 5, 2020 Category: Pharmaceuticals Authors: John George Source Type: news

Temple, Jefferson call off Fox Chase Cancer Center deal
Jefferson University and Temple University have called off the planned acquisition of Fox Chase Cancer Center by Jefferson because of the "devastating economic impact" of Covid-19. The organizations announced the termination of the transaction late Tuesday, saying the decision was amicable. “This transaction is the latest casualty of Covid-19,” said Dr. Stephen K. Klasko, president of Thomas Jefferson University and CEO of Jefferson Health. “Because of the tremendous impact that the virus… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 5, 2020 Category: Biotechnology Authors: John George Source Type: news

Alexion pays $1.4B for Bay Area biotech in bid to double commercial portfolio
With its own product portfolio under threat of competition, Alexion Pharmaceuticals Inc. is working to solidify its foothold in the red-hot blood disorder market through a $1.4 billion acquisition. Alexion (Nasdaq: ALXN) is absorbing San Francisco biotech Portola Pharmaceuticals Inc. (Nasdaq: PTLA), the companies announced Tuesday. The Boston-based biotech giant will pay $18 per share for Portola, which was trading at $7.76 per share when markets closed Monday. Portola’s stock price jumpe d nearly… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 5, 2020 Category: Biotechnology Authors: Allison DeAngelis Source Type: news

NY Pause brings health-care renovations, expansions, acquisitions to a standstill
Two years ago, 27 health-care projects were in the works across the region. The flow has now slowed to a trickle. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 2, 2020 Category: Pharmaceuticals Authors: Tracey Drury Source Type: news

NY Pause brings health-care renovations, expansions, acquisitions to a standstill
Two years ago, 27 health-care projects were in the works across the region. The flow has now slowed to a trickle. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 2, 2020 Category: Biotechnology Authors: Tracey Drury Source Type: news

New Acquisition Could Give Abiomed Access to Help COVID-19 Patients
Abiomed, maker of the Impella heart pump, could have the chance to reach some COVID-19 patients with its latest acquisition. The Danvers, MA-based company said it acquired Breethe, a developer of an extracorporeal membrane oxygenation system for an undisclosed sum. Breethe has applied for a 510K clearance of the ECMO system. The Baltimore, MD-based company’s technology has the potential to serve the needs of patients whose lungs can longer provide sufficient oxygenation, including patients suffering from cardiogenic shock, cardiac arrest or respiratory failure such as due to ARDS, H1N1, SARS, or COVID-19....
Source: MDDI - May 1, 2020 Category: Medical Devices Authors: Omar Ford Tags: COVID-19 Cardiovascular Source Type: news

Medtech in a Minute: Another Deal Bites the Dust, Telemedicine Changes the Game, and More
Another Deal Bites the Dust Citing a negative market impact from COVID-19, Alphatec backed out of its agreement to acquire EOS Imaging. While the deal is no longer feasible as contemplated, Alphatec said it is open to a strategic collaboration, if EOS is willing. Earlier this month, Organovo killed a proposed merger with Tarveda Therapeutics, but not because of the pandemic. That decision was prompted by indecisive scientific data on Organovo's part. Telemedicine Is Changing the Diabetes Game Telemedicine is emerging as the hero technology during COVID-19. In the diabetes space, the technology is enabling new patient acces...
Source: MDDI - April 30, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Motiv shifts its smart rings from health tracking to biometrics following acquisition
The company has halted sales of the Motiv Ring to consumers, but will continue to support its health tracking app for existing owners. (Source: mobihealthnews)
Source: mobihealthnews - April 29, 2020 Category: Information Technology Source Type: news

FDA updates mammo facility guidance for COVID-19
The U.S. Food and Drug Administration (FDA) on April 27 updated its guidance...Read more on AuntMinnie.comRelated Reading: FDA cuts back on U.S. inspections due to COVID-19 FDA offers mammo facility guidance for COVID-19 FDA pauses international inspections due to COVID-19 FDA recognizes AI-based image acquisition software FDA proposes electronic 510(k) submission template (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 29, 2020 Category: Radiology Source Type: news

Report: Optum in talks to buy virtual therapy provider for $470 million
UnitedHealth Group Inc.'s Optum unit is reportedly pursuing an acquisition of AbleTo, a New York provider of remote mental health services, for about $470 million. CNBC, citing sources familiar with the matter, said that the deal would value AbleTo at about 10 times forward revenue, though they noted that the terms of the acquisition could still change. Both companies declined to comment. AbleTo provides virtual mental-health treatments to patients, either via phone or text chat with its network… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 28, 2020 Category: Biotechnology Authors: Mark Reilly Source Type: news

Alphatec Pulls Out of Deal to Acquire EOS Imaging
Alphatec is pulling out of its agreement to acquire EOS Imaging because of negative impacts on the market caused by the novel coronavirus [COVID-19]. Carlsbad, CA-based Alphatec said based upon its assessment, it concluded that a “Material Adverse Effect” has occurred, resulting in circumstances that are no longer conducive to the completion of the transaction described in the terms of agreement. Instead, Alphatec said the door is open for the two companies to collaborate. The surgical spine specialist announced in late February that it would pick up EOS Imaging for $88 million, plus deb...
Source: MDDI - April 27, 2020 Category: Medical Devices Authors: Omar Ford Tags: COVID-19 Orthopedics Source Type: news

Regulator approves long-running merger plans
Regulators have approved a merger between two foundation trusts after initially blocking the plans seven years ago. (Source: HSJ)
Source: HSJ - April 27, 2020 Category: UK Health Source Type: news

JCR Pharmaceuticals announces Completion of Acquisition of ArmaGen, Inc.
ASHIYA, Japan and SAN DIEGO, April 27, 2020 -- (Healthcare Sales & Marketing Network) -- JCR Pharmaceuticals Co., Ltd. (TSE 4552; "JCR") announced that it has completed the previously announced acquisition of ArmaGen, Inc., a privately held US b... Biopharmaceuticals, Mergers & Acquisitions ArmaGen, JCR Pharmaceuticals, J-Brain Cargo (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 27, 2020 Category: Pharmaceuticals Source Type: news

With its latest acquisition, One Drop looks to integrate Sano Intelligence's CGM wearable for broader health monitoring
One Drop recently announced the acquisition of Sano's assets, IP and a portion of its staff. (Source: mobihealthnews)
Source: mobihealthnews - April 21, 2020 Category: Information Technology Source Type: news

Conformis Gets Some Economic Relief to Help with Negative COVID-19 Impact
There is a bit of relief for Conformis, a maker of custom orthopedic implants, which has been impacted significantly by the novel coronavirus (COVID-19). The Billerica, MA-based company said in a release it received $4.7 million under the paycheck protection program (PPP) offered by the U.S. Small Business Administration. In response to the coronavirus (COVID-19) pandemic, the Coronavirus Aid, Relief, and Economic Security Act authorizes the SBA to make available low-interest rate loans to qualified small businesses under the PPP. According to the terms of the PPP, all or a portion of the loan may be fully forgiven if the ...
Source: MDDI - April 21, 2020 Category: Medical Devices Tags: COVID-19 Business Source Type: news

Amblyotech, A Digital Therapeutics Company, Announces It Has Been Acquired by Novartis
Amblyotech Inc. is a clinical stage digital therapeutics company committed to the advancement of treatments and diagnostics for amblyopia (lazy eye) and other ocular disorders Acquisition will advance this innovative therapeutic program intended to trea... Biopharmaceuticals, Ophthalmology, Mergers & Acquisitions Amblyotech, Novartis, amblyopia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 20, 2020 Category: Pharmaceuticals Source Type: news

Digital Therapeutics Leader Biofourmis Expands into Oncology Market with Strategic Acquisition of Gaido Health
Acquisition of Gaido Health from Takeda Digital Ventures builds Biofourmis' digital therapeutics portfolio in oncology, while improving the care experience for cancer patients and providers BOSTON, April 16, 2020 -- (Healthcare Sales & Marketing Network... Biopharmaceuticals, Oncology, Acquisitions Biofourmis, Gaido Health, digital therapeutics, Biovitals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 16, 2020 Category: Pharmaceuticals Source Type: news

Tanzania: Govt Cancels its National Holiday Celebration as COVID Rate Rises
[VOA] Tanzania has canceled this year's April 26 national holiday celebration commemorating the 1964 merger of Tanganyika and Zanzibar to become Tanzania as the country's coronavirus tally rises. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 16, 2020 Category: African Health Source Type: news

Hanging by a thread? Forests and drought
Trees are the living foundations on which most terrestrial biodiversity is built. Central to the success of trees are their woody bodies, which connect their elevated photosynthetic canopies with the essential belowground activities of water and nutrient acquisition. The slow construction of these carbon-dense, woody skeletons leads to a slow generation time, leaving trees and forests highly susceptible to rapid changes in climate. Other long-lived, sessile organisms such as corals appear to be poorly equipped to survive rapid changes, which raises questions about the vulnerability of contemporary forests to future climate...
Source: ScienceNOW - April 16, 2020 Category: Science Authors: Brodribb, T. J., Powers, J., Cochard, H., Choat, B. Tags: Botany, Ecology special/review Source Type: news

Mylan names Coury executive chairman again
Mylan NV on Wednesday named Chairman Robert J. Coury to the role of executive chairman as the company deals with not only the COVID-19 global pandemic, but also works to complete a merger with the Upjohn unit of Pfizer Inc. It's the second time Coury has been executive chairman of the pharmaceutical company, which is now headquartered in The Netherlands but is run from its global center at Southpointe in Canonsburg. The longtime Mylan board member was CEO from 2002 to 2012 and was then executive… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 15, 2020 Category: Biotechnology Authors: Paul J. Gough Source Type: news

Mylan names Coury executive chairman again
Mylan NV on Wednesday named Chairman Robert J. Coury to the role of executive chairman as the company deals with not only the COVID-19 global pandemic, but also works to complete a merger with the Upjohn unit of Pfizer Inc. It's the second time Coury has been executive chairman of the pharmaceutical company, which is now headquartered in The Netherlands but is run from its global center at Southpointe in Canonsburg. The longtime Mylan board member was CEO from 2002 to 2012 and was then executive… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 15, 2020 Category: Pharmaceuticals Authors: Paul J. Gough Source Type: news

One Drop ’s Latest Acquisition Takes it Deeper into Telemedicine
Medtech deals are still happening despite the economic pressures brought on by the coronavirus pandemic. The latest deal sees digital health specialist One Drop acquiring all the assets and intellectual property of Sano Intelligence for an undisclosed sum.   San Francisco, CA-based Sano had developed a biometric sensor that tells a person important things about their health by revealing how the person’s body metabolizes glucose. The deal between the two was structured as an asset purchase with several members of the Sano team slated to join One Drop.   New York-based One Drop said ...
Source: MDDI - April 14, 2020 Category: Medical Devices Tags: Digital Health COVID-19 Source Type: news

FirstMedCommsJobs: The Allegro training programme – an update
To celebrate the Allegro 100 milestone, Katie Johnson (Talent Acquisition Associate) and Eleanor Thomas (Medical Writer and a graduate of the Allegro programme) joined Peter Llewelyn for a... The post FirstMedCommsJobs: The Allegro training programme – an update appeared first on Ashfield Healthcare. (Source: Ashfield Healthcare News)
Source: Ashfield Healthcare News - April 14, 2020 Category: Pharmaceuticals Authors: Ashfield Healthcare Communications Source Type: news

Adventist Health acquires community health planning venture
A recent acquisition by Roseville-based Adventist Health could see the health system play a larger role in community planning and environmental health. This week, Adventist announced that it's acquired Blue Zones LLC, a Minneapolis-based company that researches and assesses community health. Blue Zones originally started as a project for National Geographic, which was written by Blue Zone's founder, Dan Buettner, in 2005. The company name is ba sed on the concept that there are five “blue zones”… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 10, 2020 Category: Pharmaceuticals Authors: Felicia Alvarez Source Type: news

Adventist Health acquires community health planning venture
A recent acquisition by Roseville-based Adventist Health could see the health system play a larger role in community planning and environmental health. This week, Adventist announced that it's acquired Blue Zones LLC, a Minneapolis-based company that researches and assesses community health. Blue Zones originally started as a project for National Geographic, which was written by Blue Zone's founder, Dan Buettner, in 2005. The company name is ba sed on the concept that there are five “blue zones”… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 10, 2020 Category: Biotechnology Authors: Felicia Alvarez Source Type: news

Pentagon will accelerate PPE production with faster, more nimble contracts
With caps on the prototype acquisition vehicle lifted, defense officials want new ideas from industry on how to produce and decontaminate protective gear. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 9, 2020 Category: Pharmaceuticals Authors: Carten Cordell Source Type: news

Organovo Says No to Tarveda Merger
Organovo Holdings said it has terminated its merger agreement with Tarveda Therapeutics. The San Diego, CA-based company originally submitted the proposal to merge with Tarveda Therapeutics late last year. Watertown, MA-based Tarveda is a clinical-stage biopharmaceutical company developing a new class of potent and selective precision oncology medicines, which it refers to as Pentarin miniature drug conjugates. The merger proposal, which would have been an all-stock transaction, was voted down during a recent special meeting of stockholders. If the merger had gone through the combined company would have operated under the ...
Source: MDDI - April 9, 2020 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Why 'Kimtirement' is a real thing with this longtime biotech exec
After her company completed a merger in November, people told Kim Popovits to take six months off before considering anything. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 8, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Regulator: Circle merger would reduce competition in two areas
The competition regulator has said it will allow the merger of two private hospital groups if its concerns about reduced competition in two regions are resolved. (Source: HSJ)
Source: HSJ - April 8, 2020 Category: UK Health Source Type: news

Red Nucleus Acquires R & D Software Solution
Acquisition Creates Industry Game Changer(PRWeb April 08, 2020)Read the full story at https://www.prweb.com/releases/red_nucleus_acquires_r_d_software_solution/prweb17032556.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 8, 2020 Category: Pharmaceuticals Source Type: news

Allurion Files for PMA Submission of Elipse Gastric Balloon
Allurion Technologies is one step closer to having its Elipse gastric balloon enter the U.S. market. The Natick, MA-based company announced the PMA submission of the device early Tuesday. The submission comes hot on the heels of Allurion raising $34 million in new funding through a securities financing and a growth capital term loan. Allurion also announced the hiring of Joyce Johnson as VP, Regulatory Affairs and Quality Assurance. “Joyce comes to Allurion at an opportune and exciting time as we work towards receiving US regulatory approval from the FDA for the Elipse Balloon,” said Sha...
Source: MDDI - April 7, 2020 Category: Medical Devices Authors: Omar Ford Tags: Implants Regulatory and Compliance Source Type: news

Non-surgical Device for BPH Wins De Novo from FDA
FDA has granted de novo classification to a non-surgical device for the minimally invasive treatment of Benign Prostatic Hyperplasia (BPH). The iTind device was developed by Or Akiva, Israel-based Medi-Tate. However, Olympus holds the exclusive right to distribute iTind in the U.S. Here’s how iTind works. The flexible three-strut nitinol device can be placed during an in-office procedure. It expands over five days to create channels that allow urine to flow and reshape the prostate. In a release, Nacho Abia, COO of Olympus Corporation and CEO of Olympus Corporation of the Americas said, "Our investme...
Source: MDDI - April 6, 2020 Category: Medical Devices Authors: Omar Ford Tags: Regulatory and Compliance Source Type: news

More Medical Device Businesses Impacted by COVID-19
The uncertainty surrounding COVID-19 is making it difficult for public companies to accurately forecast 2020 earnings. Irvine, CA-based Endologix recently joined a growing list of medical device companies that have withdrawn previously-reported financial guidance for the year. The company makes endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once an AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. Endologix said AAA p...
Source: MDDI - April 6, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

When corporate acquisitions mean fewer ventilators
Companies often purchase competitors just to shut them down. This may be partially responsible for a shortage of ventilators in the United States. (Source: Yale Science and Health News)
Source: Yale Science and Health News - April 3, 2020 Category: Universities & Medical Training Source Type: news

COVID-19 Could Hurt Orthopedic Companies in More Ways than One
Any medical procedure that can be deffered until after the coronavirus pandemic is over will be. That means lower procedure volumes for hospitals and medical practices, which translates into lower revenue for medical device companies. One sector of the industry that stands to be heavily impacted by this is orthopedics. Canaccord Genuity analyst Kyle Rose surveyed orthopedic/spine surgeons to assess the impact on treatment patterns and practice viability. As expected, most of the 50 respondents (60%) said their organizations were defering or postponing all procedures, and about a third of respondents...
Source: MDDI - April 2, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Orthopedics Source Type: news

Haemonetics Acquires enicor GmbH to Expand Advanced Viscoelastic Testing Portfolio
BOSTON, April 2, 2020 -- (Healthcare Sales & Marketing Network) -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, today announced that it has... Devices, Mergers & Acquisitions Haemonetics, enicor GmbH, ClotPro (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 2, 2020 Category: Pharmaceuticals Source Type: news

COVID-19 Could Hurt Orthopedics Companies in More Ways than One
Any medical procedure that can be deffered until after the coronavirus pandemic is over will be. That means lower procedure volumes for hospitals and medical practices, which translates into lower revenue for medical device companies. One sector of the industry that stands to be heavily impacted by this is orthopedics. Canaccord Genuity analyst Kyle Rose surveyed orthopedic/spine surgeons to assess the impact on treatment patterns and practice viability. As expected, most of the 50 respondents (60%) said their organizations were defering or postponing all procedures, and about a third of respondents...
Source: MDDI - April 2, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Orthopedics Source Type: news

Mechanism to Reduce Medical Supply Shortfalls During Pandemics
Source: RAND Corporation. Published: 4/2020. If different regions face pandemic peaks at different points in time, supply shortfalls in regions suffering high infection caseloads (hot spots) can potentially be reduced by minimizing idle inventory and acquisitions of new supplies in regions with contemporaneously low infection caseloads (cool spots). This 16-page report discusses a potential backstopping mechanism for addressing that inefficient distribution. It also offers observations on how to evaluate whether the proposed mechanism could provide benefits over alternative responses in the ongoing coronavirus disease 201...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 1, 2020 Category: International Medicine & Public Health Source Type: news

Talcum brand Nycil gets into Sanitiser business
The sanitiser product is also the first big launch on the Heinz portfolio after its acquisition in 2018. Ahmedabad-based Zydus Wellness with Cadila Healthcare added brands like Complan, Glucon-D and Nycil to the portfolio after the acquisition of Heinz India. (Source: The Economic Times)
Source: The Economic Times - April 1, 2020 Category: Consumer Health News Source Type: news

COVID-19 News Central
Medical device companies play an essential role in combatting the novel coronavirus (COVID-19). To help, MD+DI is tracking developments in evolving regulator policies, support from medtech suppliers, and the progress being made in meeting urgent needs for medical supplies. Click on the links below for details, and monitor this page for updates. Regulations, Policies, and Government ResponseHow CDRH Is Responding to COVID-19Proposal to Postpone EU Medical Device Regulation UnderwayFDA Warns Against Fraudulent COVID-19 Tests and TreatmentsFDA Issues Emergency Guidance for Non-Invasive Remote Monitoring DevicesFDA Issues Enfo...
Source: MDDI - March 29, 2020 Category: Medical Devices Authors: MD+DI Staff Tags: Business Source Type: news

Fangs for the memories? A survey of pain in snakebite patients does not support a strong role for defense in the evolution of snake venom composition - Ward-Smith H, Arbuckle K, Naude A, W üster W.
Animals use venoms for multiple purposes, most prominently for prey acquisition and self-defense. In snakes, venom composition often evolves as a result of selection for optimization for local diet. However, whether selection for a defensive function has a... (Source: SafetyLit)
Source: SafetyLit - March 28, 2020 Category: International Medicine & Public Health Tags: Non-Human Animals and Insects Source Type: news

Medtech in a Minute: COVID-19 Impacts Business, Regulation, and More
EC pushes to postpone new medical device regulations  As the deadline for the new medical device regulations to go into force in the European Union rapidly approaches (end of May), the European Commission (EC) is looking to postpone the new regulations by one year. The delay would allow national authorities and industry to focus on urgen priorities related to the coronavirus (COVID-19) crisis, said a spokesman for the EC.   Elon Musk Talks Ventilators with Medtronic Tweets from Elon Musk and Medtronic attracted a lot of positive and negative attention. Musk said he "had a long engin...
Source: MDDI - March 28, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

ViacomCBS was facing a rough year. How the coronavirus made it even worse
ViacomCBS stock is down 68% since the merger in early December (Source: L.A. Times - Health)
Source: L.A. Times - Health - March 28, 2020 Category: Consumer Health News Authors: Meg James Source Type: news

NLM Technical Bulletin, Mar-Apr 2020, New Library Services Platform to Support Library Operations
As part of the modernization of NLM 19s infrastructure, we will be replacing the Voyager Integrated Library System with the Library Services Platform, Alma. Voyager was implemented at NLM in 1998 for library management operations, including acquisitions, cataloging, collection management, circulation, and preservation. For enhanced integration of, and public access to, the NLM collection, NLM will also replace WebVoyage Classic (LocatorPlus) and SFX OpenURL link resolver with PrimoVE. (Source: NLM Technical Bulletin)
Source: NLM Technical Bulletin - March 27, 2020 Category: Databases & Libraries Source Type: news